Shirnett Williamson
Papers
1
Total Citations
128
H-Index
1
About
Shirnett Williamson is a leading radiation oncologist whose research has fundamentally advanced the treatment of prostate cancer through stereotactic body radiation therapy (SBRT). Her landmark multicenter trial, published in 2018 and cited over 128 times, provided critical evidence that dose-escalated SBRT can be safely and effectively administered across multiple institutions for low- and intermediate-risk prostate cancer. This work demonstrated that the extreme hypofractionation inherent in SBRT aligns favorably with the radiobiology of prostate cancer, achieving excellent survival outcomes while maintaining acceptable toxicity profiles. Williamson’s contributions have been instrumental in establishing SBRT as a standard-of-care option, offering patients a more convenient and potentially less morbid treatment alternative. Her research bridges the gap between theoretical radiobiology and clinical practice, providing the robust multicenter data necessary for widespread adoption. By proving that this advanced technique can be reliably delivered beyond single-institution settings, Williamson has helped democratize access to cutting-edge radiation therapy. Her work continues to shape clinical guidelines and inspire further investigation into hypofractionated regimens, solidifying her reputation as a pivotal figure in modern radiation oncology.
Research Focus
Key Achievements
Top Papers
- 1